Portfolio company
NanoPass Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops microneedle-based intradermal delivery devices for healthcare providers and pharmaceutical companies to administer vaccines, drugs and aesthetic treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Micron Biomedical
This company develops dissolvable microarray patches for needle-free delivery of vaccines and therapeutics to patients in military and global health sectors.
PharmaJet
PharmaJet develops needle-free injection systems for healthcare providers and pharmaceutical companies to administer vaccines and liquid medications without using traditional needles.
Vaxess
This deep-tech company develops microarray patches to provide needle-free, self-administered therapy delivery for patients requiring injectable treatments such as GLP-1.
SKINPORT
This company produces hollow silicon microneedle arrays for painless drug delivery to patients and medical professionals.
Anodyne Nanotech
The company develops microneedle patches for the transdermal delivery of large-molecule medicines to patients with chronic conditions like obesity and sarcopenia.
Terrestrial Bio
This company develops needle-free, temperature-stable microarray patches for the self-administration of therapeutics and vaccines to improve patient access and outcomes.
Bioneedle Drug Delivery
Bioneedle Drug Delivery develops biodegradable needles for thermosetting vaccine and medicine administration to support global immunisation programs and pandemic preparedness.
Jurata
This company develops thermostable thin-film formulations for vaccines and biologics, enabling needle-free administration and room-temperature storage for pharmaceutical manufacturers and healthcare providers.
